Evidence map›Paper›PMID 26186507›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2015

Trends in HIV Prevalence in Pregnant Women in Rural South Africa.

Ayesha B M Kharsany, Janet A Frohlich, Nonhlanhla Yende-Zuma, Gethwana Mahlase, Natasha Samsunder, Rachael C Dellar, May Zuma-Mkhonza, Salim S Abdool Karim, Quarraisha Abdool Karim

Open access · greenAbstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Strategies to Prevent Early and Late-Onset Group BPathogens (Basel, Switzerland) · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Ayesha B M Kharsany*Centre for the AIDS Programme of Research in South Africa (CAPRISA), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa; †Zimnandi Zonke, Pietermaritzburg, South Africa; ‡uMgungundlovu Health District (D22), KwaZulu-Natal Provincial Department of Health; and §Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY.
Janet A Frohlich
Nonhlanhla Yende-Zuma
Gethwana Mahlase
Natasha Samsunder
Rachael C Dellar
May Zuma-Mkhonza
Salim S Abdool Karim
Quarraisha Abdool Karim
University of KwaZulu-Natal · ZACentre for the AIDS Programme of Research in South Africa · ZAUmkhuseli Innovation and Research Management · ZA

Funding

CAPRISA AIDS TREATMENT PROGRAMMEU2GPS001350 · PS · UNIVERSITY OF KWAZULU-NATAL · PI ABDOOL KARIM, SALIM S · 2008 to 2013
$30.7M
The Viral Set Point in HIV-1 Subtype C InfectionU19AI051794 · NIAID · UNIVERSITY OF KWAZULU-NATAL · PI ABDOOL KARIM, SALIM S · 2002 to 2007
$22.5M
TUBERCULOSIS SUPPLEMENTD43TW000231 · FIC · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI ABDOOL KARIM, QUARRAISHA · 1993 to 2014
$13.1M
FIC NIH HHS D43 TW000231FIC NIH HHS D43TW00231NCHHSTP CDC HHS U2G PS001350NIAID NIH HHS 1U19 AI51794NIAID NIH HHS U19 AI051794PHS HHS 5U2GPS001350
6 · The paper itself

Abstract

backgroundDespite substantial progress in the delivery of HIV prevention programs, some communities continue to experience high rates of HIV infection. We report on temporal trends in HIV prevalence in pregnant women in a community in rural KwaZulu-Natal in South Africa.

methodsAnnual, anonymous cross-sectional HIV sero-prevalence surveys were conducted between 2001 and 2013 among first visit prenatal clinic attendees. The time periods 2001 to 2003 were defined as pre-antiretroviral therapy (ART), 2004 to 2008 as early ART, and 2009 to 2013 as contemporary ART roll-out, to correspond with the substantial scale-up of ART program.

resultsOverall, HIV prevalence rose from 35.3% [95% confidence interval (CI): 32.3 to 38.3] pre-ART (2001-2003) to 39.0% (95% CI: 36.8 to 41.1) in the early ART (2004-2008) to 39.3% (95% CI: 37.2 to 41.4) in the contemporary ART (2009-2013) roll-out periods. In teenage women (<20 years), HIV prevalence declined from 22.5% (95% CI: 17.5 to 27.5) to 20.7% (95% CI: 17.5 to 23.8) and to 17.2% (95% CI: 14.3 to 20.2) over the similar ART roll-out periods (P = 0.046). Prevalence increased significantly in women 30 years and older (P < 0.001) over the same time period largely because of survival after ART scale up. Teenage girls with male partners of age 20-24 and ≥ 25 years had a 1.7-fold (95% CI: 1.3-2.4; P = 0.001) and 3-fold (95% CI: 2.1 to 4.3; P < 0.001) higher HIV prevalence respectively.

conclusionsNotwithstanding the encouraging decline in teenagers, the ongoing high HIV prevalence in pregnant women in this rural community, despite prevention and treatment programs, is deeply concerning. Targeted interventions for teenagers, especially for those in age-disparate relationships, are needed to impact this HIV epidemic trajectory.

Indexed as

AdolescentAdultAgingFemaleHIV InfectionsHumansMalePregnancyPregnancy Complications, InfectiousPrevalenceRural PopulationSexual PartnersSouth AfricaYoung Adult

Identifiers

PMID26186507
PMCPMC5056320
OpenAlexW2241525446

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.